1. Home
  2. FLUX vs CTXR Comparison

FLUX vs CTXR Comparison

Compare FLUX & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLUX
  • CTXR
  • Stock Information
  • Founded
  • FLUX N/A
  • CTXR 2007
  • Country
  • FLUX United States
  • CTXR United States
  • Employees
  • FLUX N/A
  • CTXR N/A
  • Industry
  • FLUX Industrial Machinery/Components
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLUX Miscellaneous
  • CTXR Health Care
  • Exchange
  • FLUX Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • FLUX 25.4M
  • CTXR 21.6M
  • IPO Year
  • FLUX N/A
  • CTXR N/A
  • Fundamental
  • Price
  • FLUX $1.83
  • CTXR $1.67
  • Analyst Decision
  • FLUX Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • FLUX 2
  • CTXR 3
  • Target Price
  • FLUX $6.00
  • CTXR $53.00
  • AVG Volume (30 Days)
  • FLUX 154.8K
  • CTXR 1.5M
  • Earning Date
  • FLUX 08-15-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • FLUX N/A
  • CTXR N/A
  • EPS Growth
  • FLUX N/A
  • CTXR N/A
  • EPS
  • FLUX N/A
  • CTXR N/A
  • Revenue
  • FLUX $63,074,000.00
  • CTXR N/A
  • Revenue This Year
  • FLUX $11.10
  • CTXR N/A
  • Revenue Next Year
  • FLUX $12.66
  • CTXR N/A
  • P/E Ratio
  • FLUX N/A
  • CTXR N/A
  • Revenue Growth
  • FLUX N/A
  • CTXR N/A
  • 52 Week Low
  • FLUX $1.15
  • CTXR $0.65
  • 52 Week High
  • FLUX $3.99
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • FLUX 48.43
  • CTXR 56.18
  • Support Level
  • FLUX $1.88
  • CTXR $1.40
  • Resistance Level
  • FLUX $2.15
  • CTXR $1.67
  • Average True Range (ATR)
  • FLUX 0.22
  • CTXR 0.18
  • MACD
  • FLUX -0.02
  • CTXR -0.03
  • Stochastic Oscillator
  • FLUX 16.25
  • CTXR 36.90

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: